Aman MG - Search Results

1

Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents.

Sherwin CM, Saldaña SN, Bies RR, Aman MG, Vinks AA. Sherwin CM, et al. Among authors: aman mg. Ther Drug Monit. 2012 Oct;34(5):535-44. doi: 10.1097/FTD.0b013e318261c240. Ther Drug Monit. 2012. PMID: 22929407 Free PMC article.

2

Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.

Aman MG, Vinks AA, Remmerie B, Mannaert E, Ramadan Y, Masty J, Lindsay RL, Malone K. Aman MG, et al. Clin Ther. 2007 Jul;29(7):1476-86. doi: 10.1016/j.clinthera.2007.07.026. Clin Ther. 2007. PMID: 17825699 Free PMC article. Clinical Trial.

3

Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry.

Flarakos J, Luo W, Aman M, Svinarov D, Gerber N, Vouros P. Flarakos J, et al. J Chromatogr A. 2004 Feb 13;1026(1-2):175-83. doi: 10.1016/j.chroma.2003.10.138. J Chromatogr A. 2004. PMID: 14763744

4

Cognitive effects of risperidone in children with autism and irritable behavior.

Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A, Cronin P, Swiezy N, Wheeler C, Koenig K, Ghuman JK, Posey DJ. Aman MG, et al. J Child Adolesc Psychopharmacol. 2008 Jun;18(3):227-36. doi: 10.1089/cap.2007.0133. J Child Adolesc Psychopharmacol. 2008. PMID: 18582177 Free PMC article. Clinical Trial.

5

Iron homeostasis during risperidone treatment in children and adolescents.

Calarge CA, Ziegler EE, Del Castillo N, Aman M, McDougle CJ, Scahill L, McCracken JT, Arnold LE. Calarge CA, et al. J Clin Psychiatry. 2015 Nov;76(11):1500-5. doi: 10.4088/JCP.14m09258. J Clin Psychiatry. 2015. PMID: 26301448 Free PMC article.

6

Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.

Findling RL, Aman MG, Eerdekens M, Derivan A, Lyons B; Risperidone Disruptive Behavior Study Group. Findling RL, et al. Among authors: aman mg. Am J Psychiatry. 2004 Apr;161(4):677-84. doi: 10.1176/appi.ajp.161.4.677. Am J Psychiatry. 2004. PMID: 15056514 Clinical Trial.

7

Discontinuation of risperidone and reversibility of weight gain in children with disruptive behavior disorders.

Lindsay RL, Leone S, Aman MG. Lindsay RL, et al. Among authors: aman mg. Clin Pediatr (Phila). 2004 Jun;43(5):437-44. doi: 10.1177/000992280404300504. Clin Pediatr (Phila). 2004. PMID: 15208748

8

Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children.

Aman MG, Hollway JA, Leone S, Masty J, Lindsay R, Nash P, Arnold LE. Aman MG, et al. Res Dev Disabil. 2009 Mar-Apr;30(2):386-96. doi: 10.1016/j.ridd.2008.07.004. Epub 2008 Sep 2. Res Dev Disabil. 2009. PMID: 18768293 Clinical Trial.

9

Pharmacotherapy of disorders in mental retardation.

Aman MG, Collier-Crespin A, Lindsay RL. Aman MG, et al. Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I98-107. doi: 10.1007/s007870070023. Eur Child Adolesc Psychiatry. 2000. PMID: 11140785 Review.

10

Acute and long-term safety and tolerability of risperidone in children with autism.

Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, Ritz L, Koenig K, McGough J, Ghuman JK, Lindsay RL. Aman MG, et al. J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84. doi: 10.1089/cap.2005.15.869. J Child Adolesc Psychopharmacol. 2005. PMID: 16379507 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters